{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-diabetic", "flavonoids", "glucose lowering", "insulin secretion", "phenolic compounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35053127", "DateRevised": {"Year": "2022", "Month": "01", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "13"}], "Language": ["eng"], "ELocationID": ["128", "10.3390/biology11010128"], "Journal": {"ISSN": "2079-7737", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "13"}}, "Title": "Biology", "ISOAbbreviation": "Biology (Basel)"}, "ArticleTitle": "<i>Teucrium polium</i>: Potential Drug Source for Type 2 Diabetes Mellitus.", "Abstract": {"AbstractText": ["The prevalence of type 2 diabetes mellitus is rising globally and this disease is proposed to be the next pandemic after COVID-19. Although the cause of type 2 diabetes mellitus is unknown, it is believed to involve a complex array of genetic defects that affect metabolic pathways which eventually lead to hyperglycaemia. This hyperglycaemia arises from an inability of the insulin-sensitive cells to sufficiently respond to the secreted insulin, which eventually results in the inadequate secretion of insulin from pancreatic \u03b2-cells. Several treatments, utilising a variety of mechanisms, are available for type 2 diabetes mellitus. However, more medications are needed to assist with the optimal management of the different stages of the disease in patients of varying ages with the diverse combinations of other medications co-administered. Throughout modern history, some lead constituents from ancient medicinal plants have been investigated extensively and helped in developing synthetic antidiabetic drugs, such as metformin. <i>Teucrium polium</i> L. (<i>Tp</i>) is a herb that has a folk reputation for its antidiabetic potential. Previous studies indicate that <i>Tp</i> extracts significantly decrease blood glucose levels <i>r</i> and induce insulin secretion from pancreatic \u03b2-cells in vitro. Nonetheless, the constituent/s responsible for this action have not yet been elucidated. The effects appear to be, at least in part, attributable to the presence of selected flavonoids (apigenin, quercetin, and rutin). This review aims to examine the reported glucose-lowering effect of the herb, with a keen focus on insulin secretion, specifically related to type 2 diabetes mellitus. An analysis of the contribution of the key constituent flavonoids of <i>Tp</i> extracts will also be discussed."]}, "AuthorList": [{"Identifier": ["0000-0002-8905-9804"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Curtin Medical School, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia."}], "LastName": "Albadr", "ForeName": "Yaser", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Curtin Medical School, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia."}], "LastName": "Crowe", "ForeName": "Andrew", "Initials": "A"}, {"Identifier": ["0000-0002-9363-1797"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Curtin Medical School, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA 6102, Australia."}], "LastName": "Caccetta", "ForeName": "Rima", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biology (Basel)", "NlmUniqueID": "101587988", "ISSNLinking": "2079-7737"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41((Suppl. 1)):S13\u2013S27. doi: 10.2337/dc18-S002.", "ArticleIdList": ["10.2337/dc18-S002", "29222373"]}, {"Citation": "World Health Organisation  Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. 2006.  [(accessed on 19 December 2021)].  Available online:  https://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf."}, {"Citation": "International Diabetes Federation Diabetes is \u201ca pandemic of unprecedented magnitude\u201d now affecting one in 10 adults worldwide. Diabetes Res. Clin. Pract. 2021;181:109133. doi: 10.1016/j.diabres.2021.109133.", "ArticleIdList": ["10.1016/j.diabres.2021.109133", "34801177"]}, {"Citation": "Parohan M., Yaghoubi S., Seraji A., Javanbakht M.H., Sarraf P., Djalali M. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. Aging Male. 2020;23:1416\u20131424. doi: 10.1080/13685538.2020.1774748.", "ArticleIdList": ["10.1080/13685538.2020.1774748", "32508193"]}, {"Citation": "Apicella M., Campopiano M.C., Mantuano M., Mazoni L., Coppelli A., Del Prato S. COVID-19 in people with diabetes: Understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8:782\u2013792. doi: 10.1016/S2213-8587(20)30238-2.", "ArticleIdList": ["10.1016/S2213-8587(20)30238-2", "PMC7367664", "32687793"]}, {"Citation": "Erener S. Diabetes, infection risk and COVID-19. Mol. Metab. 2020;39:101044. doi: 10.1016/j.molmet.2020.101044.", "ArticleIdList": ["10.1016/j.molmet.2020.101044", "PMC7308743", "32585364"]}, {"Citation": "Ghosal S., Arora B., Dutta K., Ghosh A., Sinha B., Misra A. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:949\u2013952. doi: 10.1016/j.dsx.2020.06.020.", "ArticleIdList": ["10.1016/j.dsx.2020.06.020", "PMC7303633", "32604013"]}, {"Citation": "Zhang Y., Ma Z.F. Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: A cross-sectional study. Int. J. Environ. Res. Public Health. 2020;17:2381. doi: 10.3390/ijerph17072381.", "ArticleIdList": ["10.3390/ijerph17072381", "PMC7177660", "32244498"]}, {"Citation": "Mendis S., Bettcher D., Branca F. World Health Organization Global Status Report on Noncommunicable Diseases. 2014.  [(accessed on 19 December 2021)].  Available online:  http://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf;jsessionid=39235CE69F7E48BF856DAFA5E81A8D0B?sequence=1."}, {"Citation": "Cho N.H., Shaw J.E., Karuranga S., Huang Y., da Rocha Fernandes J.D., Ohlrogge A.W., Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271\u2013281. doi: 10.1016/j.diabres.2018.02.023.", "ArticleIdList": ["10.1016/j.diabres.2018.02.023", "29496507"]}, {"Citation": "World Health Organizations  Global Report on Diabetes: Global Burden of Diabetes. 2016.  [(accessed on 19 December 2021)].  Available online:  http://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf?sequence=1."}, {"Citation": "Udler M.S. Type 2 Diabetes: Multiple Genes, Multiple Diseases. Curr. Diabetes Rep. 2019;19:55. doi: 10.1007/s11892-019-1169-7.", "ArticleIdList": ["10.1007/s11892-019-1169-7", "PMC6620259", "31292748"]}, {"Citation": "Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: Pathgenesis and treatment. Lancet. 2008;371:2153\u20132156. doi: 10.1016/S0140-6736(08)60932-0.", "ArticleIdList": ["10.1016/S0140-6736(08)60932-0", "18586159"]}, {"Citation": "Ali O. Genetics of type 2 diabetes. World J. Diabetes. 2013;4:114\u2013123. doi: 10.4239/wjd.v4.i4.114.", "ArticleIdList": ["10.4239/wjd.v4.i4.114", "PMC3746083", "23961321"]}, {"Citation": "Rudenski A.S., Hadden D.R., Atkinson A.B., Kennedy L., Matthews D.R., Merrett J.D., Pockaj B., Turner R.C. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet. Med. 1988;5:36\u201341. doi: 10.1111/j.1464-5491.1988.tb00938.x.", "ArticleIdList": ["10.1111/j.1464-5491.1988.tb00938.x", "2964326"]}, {"Citation": "Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes. 2005;54((Suppl. 2)):S97\u2013S107. doi: 10.2337/diabetes.54.suppl_2.S97.", "ArticleIdList": ["10.2337/diabetes.54.suppl_2.S97", "16306347"]}, {"Citation": "Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. \u03b2-Cell Deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102\u2013110. doi: 10.2337/diabetes.52.1.102.", "ArticleIdList": ["10.2337/diabetes.52.1.102", "12502499"]}, {"Citation": "Armstrong A.C., Ambale-Venkatesh B., Turkbey E., Donekal S., Chamera E., Backlund J.Y., Cleary P., Lachin J., Bluemke D.A., Lima J.A.C., et al. Association of cardiovascular risk factors and myocardial fibrosis with early cardiac dysfunction in type 1 diabetes: The diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2017;40:405\u2013411. doi: 10.2337/dc16-1889.", "ArticleIdList": ["10.2337/dc16-1889", "PMC5319473", "27986796"]}, {"Citation": "Chakrabarti R., Rajagopalan R. Diabetes and insulin resistance associated disorders: Disease and the therapy. Curr. Sci. 2002;83:1533\u20131538."}, {"Citation": "Miller E., Aguilar R.B., Herman M.E., Schwartz S.S. Type 2 diabetes: Evolving concepts and treatment. Clevel. Clin. J. Med. 2019;86:494\u2013504. doi: 10.3949/ccjm.86a.17107.", "ArticleIdList": ["10.3949/ccjm.86a.17107", "31291183"]}, {"Citation": "Gerich J.E. Control of glycaemia. Baillieres Clin. Endocrinol. Metab. 1993;7:551\u2013586. doi: 10.1016/S0950-351X(05)80207-1.", "ArticleIdList": ["10.1016/S0950-351X(05)80207-1", "8379904"]}, {"Citation": "Greiner E.F., Guppy M., Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 1994;269:31484\u201331490. doi: 10.1016/S0021-9258(18)31720-4.", "ArticleIdList": ["10.1016/S0021-9258(18)31720-4", "7989314"]}, {"Citation": "Fu Z., Gilbert E.R., Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr. Diabetes Rev. 2013;9:25\u201353. doi: 10.2174/157339913804143225.", "ArticleIdList": ["10.2174/157339913804143225", "PMC3934755", "22974359"]}, {"Citation": "Doyle-Delgado K., Chamberlain J.J., Shubrook J.H., Skolnik N., Trujillo J. Pharmacologic approaches to glycemic treatment of type 2 diabetes: Synopsis of the 2020 American Diabetes Association\u2019s Standards of Medical Care in Diabetes clinical guideline. Ann. Intern. Med. 2020;173:813\u2013821. doi: 10.7326/M20-2470.", "ArticleIdList": ["10.7326/M20-2470", "32866414"]}, {"Citation": "Pe\u00f1a A.S., Curran J.A., Fuery M., George C., Jefferies C.A., Lobley K., Ludwig K., Maguire A.M., Papadimos E., Peters A., et al. Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines. Med. J. Aust. 2020;213:30\u201343. doi: 10.5694/mja2.50666.", "ArticleIdList": ["10.5694/mja2.50666", "32578226"]}, {"Citation": "Buse J.B., Wexler D.J., Tsapas A., Rossing P., Mingrone G., Mathieu C., D\u2019Alessio D.A., Davies M.J. 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2020;43:487\u2013493. doi: 10.2337/dci19-0066.", "ArticleIdList": ["10.2337/dci19-0066", "PMC6971782", "31857443"]}, {"Citation": "Cantello B.C.C., Cawthorne M.A., Cottam G.P., Duff P.T., Haigh D., Hindley R.M., Lister C.A., Smith S.A., Thurlby P.L. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 1994;37:3977\u20133985. doi: 10.1021/jm00049a017.", "ArticleIdList": ["10.1021/jm00049a017", "7966158"]}, {"Citation": "Drucker D.J. Glucagon-like peptides. Diabetes. 1998;47:159\u2013169. doi: 10.2337/diab.47.2.159.", "ArticleIdList": ["10.2337/diab.47.2.159", "9519708"]}, {"Citation": "Porksen N.K., Munn S.R., Steers J.L., Schmitz O., Veldhuis J.D., Butler P.C. Mechanisms of sulfonylurea\u2019s stimulation of insulin secretion in vivo: Selective amplification of insulin secretory burst mass. Diabetes. 1996;45:1792\u20131797. doi: 10.2337/diab.45.12.1792.", "ArticleIdList": ["10.2337/diab.45.12.1792", "8922367"]}, {"Citation": "Read P.A., Khan F.Z., Heck P.M., Hoole S.P., Dutka D.P. DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease. Circ. Cardiovasc. Imaging. 2010;3:195\u2013201. doi: 10.1161/CIRCIMAGING.109.899377.", "ArticleIdList": ["10.1161/CIRCIMAGING.109.899377", "20075143"]}, {"Citation": "Van de Laar F.A., Lucassen P.L., Akkermans R.P., Van de Lisdonk E.H., Rutten G.E., Van Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2005;2009:CD003639. doi: 10.1002/14651858.CD003639.pub2.", "ArticleIdList": ["10.1002/14651858.CD003639.pub2", "PMC8406605", "15846673"]}, {"Citation": "Bailey C.J., Turner R.C. Metformin. N. Engl. J. Med. 1996;334:574\u2013579. doi: 10.1056/NEJM199602293340906.", "ArticleIdList": ["10.1056/NEJM199602293340906", "8569826"]}, {"Citation": "Grunberger G. Should side effects influence the selection of antidiabetic therapies in type 2 diabetes? Curr. Diabetes Rep. 2017;17:21. doi: 10.1007/s11892-017-0853-8.", "ArticleIdList": ["10.1007/s11892-017-0853-8", "28293908"]}, {"Citation": "Scheen A.J., Paquot N. Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 2013;39:179\u2013190. doi: 10.1016/j.diabet.2013.02.006.", "ArticleIdList": ["10.1016/j.diabet.2013.02.006", "23528671"]}, {"Citation": "Gheissari A., Hemmatzadeh S., Merrikhi A., Fadaei Tehrani S., Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J. Nephropathol. 2012;1:177\u2013182. doi: 10.5812/nephropathol.8119.", "ArticleIdList": ["10.5812/nephropathol.8119", "PMC3886143", "24475412"]}, {"Citation": "Davoren P. Safe prescribing of metformin in diabetes. Aust. Prescr. 2014;37:2\u20135. doi: 10.18773/austprescr.2014.001.", "ArticleIdList": ["10.18773/austprescr.2014.001"]}, {"Citation": "Pandey A., Tripathi P., Pandey R., Srivatava R., Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J. Pharm. Bioallied Sci. 2011;3:504\u2013512.", "ArticleIdList": ["PMC3249697", "22219583"]}, {"Citation": "Alam F., Islam M.A., Kamal M.A., Gan S.H. Updates on managing type 2 diabetes mellitus with natural products: Towards antidiabetic drug development. Curr. Med. Chem. 2018;25:5395\u20135431. doi: 10.2174/0929867323666160813222436.", "ArticleIdList": ["10.2174/0929867323666160813222436", "27528060"]}, {"Citation": "Saad B., Zaid H., Shanak S., Kadan S. Anti-Diabetes and Anti-Obesity Medicinal Plants and Phytochemicals. Springer; Cham, Switzerland: 2017."}, {"Citation": "Hawash M., Jaradat N., Elaraj J., Hamdan A., Abu Lebdeh S., Halawa T. Evaluation of the hypoglycemic effect of seven wild folkloric edible plants from Palestine: Antidiabetic effect of seven plants from Palestine. J. Complement. Integr. Med. 2019;17:20190032. doi: 10.1515/jcim-2019-0032.", "ArticleIdList": ["10.1515/jcim-2019-0032", "31323003"]}, {"Citation": "Perla V., Jayanty S.S. Biguanide related compounds in traditional antidiabetic functional foods. Food Chem. 2013;138:1574\u20131580. doi: 10.1016/j.foodchem.2012.09.125.", "ArticleIdList": ["10.1016/j.foodchem.2012.09.125", "23411283"]}, {"Citation": "Nyenwe E.A., Jerkins T.W., Umpierrez G.E., Kitabchi A.E. Management of type 2 diabetes: Evolving strategies for the treatment of patients with type 2 diabetes. Metabolism. 2011;60:1\u201323. doi: 10.1016/j.metabol.2010.09.010.", "ArticleIdList": ["10.1016/j.metabol.2010.09.010", "PMC3746516", "21134520"]}, {"Citation": "Saad B., Said O. Greco-Arab and Islamic Herbal Medicine: Traditional System, Ethics, Safety, Efficacy, and Regulatory Issues. John Wiley & Sons; Hoboken, NJ, USA: 2011."}, {"Citation": "Arumugam G., Manjula P., Paari N. A review: Anti diabetic medicinal plants used for diabetes mellitus. J. Acute Dis. 2013;2:196\u2013200. doi: 10.1016/S2221-6189(13)60126-2.", "ArticleIdList": ["10.1016/S2221-6189(13)60126-2"]}, {"Citation": "Patel D.K., Prasad S.K., Kumar R., Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2012;2:320\u2013330. doi: 10.1016/S2221-1691(12)60032-X.", "ArticleIdList": ["10.1016/S2221-1691(12)60032-X", "PMC3609288", "23569923"]}, {"Citation": "Asghari A.A., Mokhtari-Zaer A., Niazmand S., Mc Entee K., Mahmoudabady M. Anti-diabetic properities and bioactive compounds of Teucrium polium L. Asian Pac. J. Trop. Biomed. 2020;10:433\u2013441. doi: 10.4103/2221-1691.290868.", "ArticleIdList": ["10.4103/2221-1691.290868"]}, {"Citation": "Kasabri V., Abu-Dahab R., Afifi F.U., Naffa R., Majdalawi L. In vitro modulation of pancreatic MIN6 insulin secretion and proliferation and extrapancreatic glucose absorption by paronechia argentea, Rheum ribes and Teucrium polium extracts. Jordan J. Pharm. Sci. 2012;5:203\u2013219."}, {"Citation": "Mannan A. Molecular Signaling Pathways Involved in the Glucose-Lowering Effect of Teucrium Polium. Curtin University; Perth, WA, Australia: 2017."}, {"Citation": "Mirghazanfari S.M., Keshavarz M., Nabavizadeh F., Soltani N., Kamalinejad M. The Effect of Teucrium polium L. extracts on insulin release from in situ isolated perfused rat pancreas in a newly modified isolation method: The role of Ca2+ and K+ Channels. Iran. Biomed. J. 2010;14:178\u2013185.", "ArticleIdList": ["PMC3632428", "21283261"]}, {"Citation": "Stefkov G., Kulevanova S., Miova B., Dinevska-Kjovkarovska S., M\u00f8lgaard P., J\u00e4ger A.K., Josefsen K. Effects of Teucrium polium spp. capitatum flavonoids on the lipid and carbohydrate metabolism in rats. Pharm. Biol. 2011;49:885\u2013892. doi: 10.3109/13880209.2011.552187.", "ArticleIdList": ["10.3109/13880209.2011.552187", "21619454"]}, {"Citation": "Fujii M., Takei I., Umezawa K. Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats. Biomed. Pharmacother. 2009;63:710\u2013716. doi: 10.1016/j.biopha.2009.01.006.", "ArticleIdList": ["10.1016/j.biopha.2009.01.006", "19217246"]}, {"Citation": "Ramkumar K.M., Lee A.S., Krishnamurthi K., Devi S.S., Chakrabarti T., Kang K.P., Lee S., Kim W., Park S.K., Lee N.H., et al. Gymnema montanum H. protects against alloxan-induced oxidative stress and apoptosis in pancreatic \u03b2-cells. Cell. Physiol. Biochem. 2009;24:429\u2013440. doi: 10.1159/000257480.", "ArticleIdList": ["10.1159/000257480", "19910683"]}, {"Citation": "Yahaya N., Mohd Dom N.S., Adam Z., Hamid M. Insulinotropic activity of standardized methanolic extracts of Ficus deltoidea from seven varieties. Evid. Based Complement. Altern. Med. 2018;2018:3769874. doi: 10.1155/2018/3769874.", "ArticleIdList": ["10.1155/2018/3769874", "PMC6038492", "30046337"]}, {"Citation": "Chien S.-C., Young P.H., Hsu Y.-J., Chen C.-H., Tien Y.-J., Shiu S.-Y., Li T.-H., Yang C.-W., Marimuthu P., Tsai L.F.-L., et al. Anti-diabetic properties of three common Bidens pilosa variants in Taiwan. Phytochemistry. 2009;70:1246\u20131254. doi: 10.1016/j.phytochem.2009.07.011.", "ArticleIdList": ["10.1016/j.phytochem.2009.07.011", "19683775"]}, {"Citation": "Ireng A., Helmerhorst E., Parsons R., Caccetta R. Teucrium polium significantly lowers blood glucose levels acutely in normoglycemic male Wistar rats: A comparative to insulin and metformin. Adv. Med. Plant. Res. 2016;4:1\u201310."}, {"Citation": "Frezza C., Venditti A., Serafini M., Bianco A. Chapter 4: Phytochemistry, Chemotaxonomy, Ethnopharmacology, and Nutraceutics of Lamiaceae. In: Atta-ur-Rahma, editor. Studies in Natural Products Chemistry. Volume 62. Elsevier; Amestrdam, The Netherlands: 2019. pp. 125\u2013178."}, {"Citation": "Venditti A., Frezza C., Zadeh S.M.M., Foddai S., Serafini M., Bianco A. Secondary metabolites from Teucrium polium L. collected in Southern Iran. AJMAP. 2017;3:108\u2013123."}, {"Citation": "Hasani-Ranjbar S., Nayebi N., Larijani B., Abdollahi M. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int. J. Pharmacol. 2010;6:315\u2013325. doi: 10.3923/ijp.2010.315.325.", "ArticleIdList": ["10.3923/ijp.2010.315.325"]}, {"Citation": "Mazokopakis E., Lazaridou S., Tzardi M., Mixaki J., Diamantis I., Ganotakis E. Acute cholestatic hepatitis caused by Teucrium polium L. Phytomedicine. 2004;11:83\u201384. doi: 10.1078/0944-7113-00337.", "ArticleIdList": ["10.1078/0944-7113-00337", "14971726"]}, {"Citation": "Gray A.I., Igoli J.O., Edrada-Ebel R. Natural products isolation in modern drug discovery programs. Methods Mol. Biol. 2012;864:515\u2013534.", "ArticleIdList": ["22367910"]}, {"Citation": "Thomford N.E., Senthebane D.A., Rowe A., Munro D., Seele P., Maroyi A., Dzobo K. Natural products for drug discovery in the 21st Century: Innovations for novel drug discovery. Int. J. Mol. Sci. 2018;19:1578. doi: 10.3390/ijms19061578.", "ArticleIdList": ["10.3390/ijms19061578", "PMC6032166", "29799486"]}, {"Citation": "Yaniv Z., Dafni A., Friedman J., Palevitch D. Plants used for the treatment of diabetes in Israel. J. Ethnopharmacol. 1987;19:145\u2013151. doi: 10.1016/0378-8741(87)90038-9.", "ArticleIdList": ["10.1016/0378-8741(87)90038-9", "3613607"]}, {"Citation": "Ardestani A., Yazdanparast R., Jamshidi S. Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats. J. Med. Food. 2008;11:525\u2013532. doi: 10.1089/jmf.2006.0230.", "ArticleIdList": ["10.1089/jmf.2006.0230", "18800902"]}, {"Citation": "Yazdanparas R., Esmaeili M.A., Ashrafi Helan J. Teucrium polium extract effects pancreatic function of streptozotocin diabetic rats: A histopathological examination. Iran. Biomed. J. 2005;9:81\u201385."}, {"Citation": "Gharaibeh M.N., Elayan H.H., Salhab A.S. Hypoglycemic effects of Teucrium polium. J. Ethnopharmacol. 1988;24:93\u201399. doi: 10.1016/0378-8741(88)90139-0.", "ArticleIdList": ["10.1016/0378-8741(88)90139-0", "3199839"]}, {"Citation": "Vessal M., Hemmati M., Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2003;135:357\u2013364. doi: 10.1016/S1532-0456(03)00140-6.", "ArticleIdList": ["10.1016/S1532-0456(03)00140-6", "12927910"]}, {"Citation": "Stankovic M.S., Niciforovic N., Mihailovic V., Topuzovic M., Solujic S. Antioxidant activity, total phenolic content and flavonoid concentrations of different plant parts of Teucrium polium L. subsp. polium. Acta Soc. Bot. Pol. 2012;81:117\u2013122. doi: 10.5586/asbp.2012.010.", "ArticleIdList": ["10.5586/asbp.2012.010"]}, {"Citation": "Sharififar F., Dehghn-Nudeh G., Mirtajaldini M. Major flavonoids with antioxidant activity from Teucrium polium L. Food Chem. 2009;112:885\u2013888. doi: 10.1016/j.foodchem.2008.06.064.", "ArticleIdList": ["10.1016/j.foodchem.2008.06.064"]}, {"Citation": "Pacifico S., D\u2019Abrosca B., Scognamiglio M., D\u2019Angelo G., Gallicchio M., Galasso S., Monaco P., Fiorentino A. NMR-based metabolic profiling and in vitro antioxidant and hepatotoxic assessment of partially purified fractions from Golden germander (Teucrium polium L.) methanolic extract. Food Chem. 2012;135:1957\u20131967. doi: 10.1016/j.foodchem.2012.06.071.", "ArticleIdList": ["10.1016/j.foodchem.2012.06.071", "22953945"]}, {"Citation": "Farahmandfar R., Asnaashari M., Bakhshandeh T. Influence of ultrasound-assist and classical extractions on total phenolic, tannin, flavonoids, tocopherol and antioxidant characteristics of Teucrium polium aerial parts. J. Food Meas. Charact. 2019;13:1357\u20131363. doi: 10.1007/s11694-019-00051-5.", "ArticleIdList": ["10.1007/s11694-019-00051-5"]}, {"Citation": "Esmaeili M.A., Zohari F., Sadeghi H. Antioxidant and protective effects of major flavonoids from Teucrium polium on \u03b2-cell destruction in a model of streptozotocin-induced diabetes. Planta Med. 2009;75:1418\u20131420. doi: 10.1055/s-0029-1185704.", "ArticleIdList": ["10.1055/s-0029-1185704", "19452438"]}, {"Citation": "Rauter A.P., Martins A., Borges C., Mota-Filipe H., Pinto R.M., Sepodes B., Justino J. Antihyperglycaemic and protective effects of flavonoids on streptozotocin\u2013induced diabetic rats. Phytother. Res. 2010;24((Suppl. 2)):S133\u2013S138. doi: 10.1002/ptr.3017.", "ArticleIdList": ["10.1002/ptr.3017", "20309949"]}, {"Citation": "Osigwe C.C., Akah P.A., Nworu C.S., Okoye F.B. Apigenin: A methanol fraction component of Newbouldia laevis leaf, as a potential antidiabetic agent. J. Phytopharm. 2017;6:38\u201344. doi: 10.31254/phyto.2017.6106.", "ArticleIdList": ["10.31254/phyto.2017.6106"]}, {"Citation": "Bansal P., Paul P., Mudgal J., Nayak P.G., Pannakal S.T., Priyadarsini K., Unnikrishnan M. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Exp. Toxicol. Pathol. 2012;64:651\u2013658. doi: 10.1016/j.etp.2010.12.009.", "ArticleIdList": ["10.1016/j.etp.2010.12.009", "21208790"]}, {"Citation": "Kawabata K., Yoshioka Y., Terao J. Role of intestinal microbiota in the bioavailability and physiological functions of dietary polyphenols. Molecules. 2019;24:370. doi: 10.3390/molecules24020370.", "ArticleIdList": ["10.3390/molecules24020370", "PMC6359708", "30669635"]}, {"Citation": "Dias M.C., Pinto D.C.G.A., Silva A.M.S. Plant flavonoids: Chemical characteristics and biological activity. Molecules. 2021;26:5377. doi: 10.3390/molecules26175377.", "ArticleIdList": ["10.3390/molecules26175377", "PMC8434187", "34500810"]}, {"Citation": "Rodriguez-Daza M.C., Pulido-Mateos E.C., Lupien-Meilleur J., Guyonnet D., Desjardins Y., Roy D. Polyphenol-mediated gut microbiota modulation: Toward prebiotics and further. Front. Nutr. 2021;8:689456. doi: 10.3389/fnut.2021.689456.", "ArticleIdList": ["10.3389/fnut.2021.689456", "PMC8276758", "34268328"]}, {"Citation": "Ali F., Rahul Naz F., Jyoti S., Siddique Y.H. Health functionality of apigenin: A review. Int. J. Food Prop. 2017;20:1197\u20131238. doi: 10.1080/10942912.2016.1207188.", "ArticleIdList": ["10.1080/10942912.2016.1207188"]}, {"Citation": "D\u2019Abrosca B., Pacifico S., Scognamiglio M., D\u2019Angelo G., Galasso S., Monaco P., Fiorentino A. A new acylated flavone glycoside with antioxidant and radical scavenging activities from Teucrium polium leaves. Nat. Prod. Res. 2013;27:356\u2013363. doi: 10.1080/14786419.2012.695367.", "ArticleIdList": ["10.1080/14786419.2012.695367", "22708583"]}, {"Citation": "Kawashty S., El-Din E.G., Saleh N. The flavonoid chemosystematics of two Teucrium species from Southern Sinai, Egypt. Biochem. Syst. Ecol. 1999;27:657\u2013660. doi: 10.1016/S0305-1978(97)00109-9.", "ArticleIdList": ["10.1016/S0305-1978(97)00109-9"]}, {"Citation": "Esmaeili M.A., Sadeghi H. Pancreatic \u0392-cell protective effect of rutin and apigenin isolated from Teucrium polium. Pharmacologyonline. 2009;2:341\u2013353."}, {"Citation": "Hossain C.M., Ghosh M.K., Satapathy B.S., Dey N.S., Mukherjee B. Apigenin causes biochemical modulation, GLUT4 and CD38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am. J. Pharmacol. Toxicol. 2014;9:39\u201352. doi: 10.3844/ajptsp.2014.39.52.", "ArticleIdList": ["10.3844/ajptsp.2014.39.52"]}, {"Citation": "Alam M.M., Meerza D., Naseem I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci. 2014;109:8. doi: 10.1016/j.lfs.2014.06.005.", "ArticleIdList": ["10.1016/j.lfs.2014.06.005", "24946265"]}, {"Citation": "Kamalakkannan N., Prince P.S.M. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin. Pharmacol. Toxicol. 2006;98:97\u2013103. doi: 10.1111/j.1742-7843.2006.pto_241.x.", "ArticleIdList": ["10.1111/j.1742-7843.2006.pto_241.x", "16433898"]}, {"Citation": "Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., Richard J., Quignard J.F., Gross R., Petit P., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic \u03b2-cells against oxidative damage via the ERK1/2 pathway. Br. J. Pharmacol. 2010;161:799\u2013814. doi: 10.1111/j.1476-5381.2010.00910.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00910.x", "PMC2992896", "20860660"]}, {"Citation": "Eid H.M., Nachar A., Thong F., Sweeney G., Haddad P.S. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn. Mag. 2015;11:74\u201381.", "ArticleIdList": ["PMC4329636", "25709214"]}, {"Citation": "Walle T., Browning A.M., Steed L.L., Reed S.G., Walle U.K. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J. Nutr. 2005;135:48\u201352. doi: 10.1093/jn/135.1.48.", "ArticleIdList": ["10.1093/jn/135.1.48", "15623831"]}, {"Citation": "Day A.J., DuPont M.S., Ridley S., Rhodes M., Rhodes M.J., Morgan M.R., Williamson G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 1998;436:71\u201375. doi: 10.1016/S0014-5793(98)01101-6.", "ArticleIdList": ["10.1016/S0014-5793(98)01101-6", "9771896"]}, {"Citation": "Spencer J.P., Chowrimootoo G., Choudhury R., Debnam E.S., Srai S.K., Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999;458:224\u2013230. doi: 10.1016/S0014-5793(99)01160-6.", "ArticleIdList": ["10.1016/S0014-5793(99)01160-6", "10481070"]}, {"Citation": "Chen J., Lin H., Hu M. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition. J. Pharmacol. Exp. Ther. 2003;304:1228\u20131235. doi: 10.1124/jpet.102.046409.", "ArticleIdList": ["10.1124/jpet.102.046409", "12604700"]}, {"Citation": "Gradolatto A., Canivenc-Lavier M.C., Basly J.P., Siess M.H., Teyssier C. Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. Drug Metab. Dispos. 2004;32:58\u201365. doi: 10.1124/dmd.32.1.58.", "ArticleIdList": ["10.1124/dmd.32.1.58", "14709621"]}, {"Citation": "Manach C., Morand C., Crespy V., Demign\u00e9 C., Texier O., R\u00e9g\u00e9rat F., R\u00e9m\u00e9sy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett. 1998;426:331\u2013336. doi: 10.1016/S0014-5793(98)00367-6.", "ArticleIdList": ["10.1016/S0014-5793(98)00367-6", "9600261"]}, {"Citation": "Lee J., Ebeler S.E., Zweigenbaum J.A., Mitchell A.E. UHPLC-(ESI) QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of apple sauce enriched with apple peel and onion. J. Agric. Food Chem. 2012;60:8510\u20138520. doi: 10.1021/jf302637t.", "ArticleIdList": ["10.1021/jf302637t", "22867437"]}, {"Citation": "Bell J.R., Donovan J.L., Wong R., Waterhouse A.L., German J.B., Walzem R.L., Kasim-Karakas S.E. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am. J. Clin. Nutr. 2000;71:103\u2013108. doi: 10.1093/ajcn/71.1.103.", "ArticleIdList": ["10.1093/ajcn/71.1.103", "10617953"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "6"}, {"Year": "2022", "Month": "1", "Day": "10"}, {"Year": "2022", "Month": "1", "Day": "21", "Hour": "1", "Minute": "4"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["35053127", "PMC8772689", "10.3390/biology11010128", "biology11010128"]}}], "PubmedBookArticle": []}